NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Arrivo BioVentures

Arrivo BioVentures

Private
Morrisville, North CarolinaHealthcare & Life Scienceshttps://arrivobio.com/

Last Round

Series B

Nov 29, 2023

Total Funding Raised

$45.25M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Arrivo BioVentures is a biopharmaceutical company that develops first-of-its-kind medicines targeting the root causes of hard-to-treat diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldrug developmentsmall molecule therapeuticsbiological therapeuticsbiotech startupclinical-stage assetshomeostasis researchdrug discoverypreclinical developmentlicensing agreementsbiotech incubatortherapeutic pipelineventure-backed biotechbiotech venture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arrivo BioVentures Comparables

Compare Arrivo BioVentures with similar companies based on industry and business-model similarity.

Arrivo BioVentures comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CinRx Pharma
76%
Apollo Therapeutics
70%
ApoGlyx
66%

Arrivo BioVentures Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 29, 2023
VC RoundMay 25, 2016

Arrivo BioVentures Investors

Notable investors and investment history

Arrivo BioVentures investors
InvestorRounds
Orlando Health VenturesSeries B
Solas BioVenturesVC Round, Series B
Rex Health VenturesVC Round, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 31% MoM.

  • Nov 29, 2023

    $45.25M round led by Orlando Health Ventures

Arrivo BioVentures Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arrivo BioVentures Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arrivo BioVentures's valuation, stock price, and market status.

Firmographic Details

HeadquartersMorrisville, North Carolina
Employee Range15
Year Founded2015
Last FundingNov 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.